Thermal ablation for small renal masses: Identifying the most appropriate tumor size cut-off for predicting perioperative and oncological outcomes.
暂无分享,去创建一个
F. Orsi | O. de Cobelli | M. Ferro | G. Mauri | A. Marmiroli | F. Mistretta | G. Varano | G. Musi | G. Bonomo | P. Della Vigna | D. Maiettini | Nicola Camisassi | S. Luzzago | R. Bianchi | E. di Trapani | C. Vaccaro | Gaia Ghilardi
[1] N. Kelekis,et al. Computed Tomography-Guided Percutaneous Microwave Ablation for Renal Cell Carcinoma: Impact of Tumor Size on the Progression Survival Rates , 2021, Diagnostics.
[2] Sam S. Chang,et al. Renal Mass and Localized Renal Cancer: Evaluation, Management, and Follow-Up: AUA Guideline: Part I , 2021, The Journal of urology.
[3] X. Cathelineau,et al. Optimal Surgical Outcome of Minimally Invasive Partial Nephrectomy (MIPN) Based on an Early Postoperative Estimated Glomerular Filtration Rate (eGFR) , 2021, Current Urology Reports.
[4] U. Capitanio,et al. Collaborative Review: Factors Influencing Treatment Decisions for Patients with a Localized Solid Renal Mass. , 2021, European urology.
[5] L. Solbiati,et al. Real-Time US-CT fusion imaging for guidance of thermal ablation in of renal tumors invisible or poorly visible with US: results in 97 cases , 2021, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.
[6] R. Arellano,et al. Percutaneous Microwave Ablation of Stage T1b Renal Cell Carcinoma: Short-Term Assessment of Technical Feasibility, Short-Term Oncologic Outcomes, and Safety. , 2020, Journal of endourology.
[7] F. Orsi,et al. Long-Term Follow-Up Outcomes after Percutaneous US/CT-Guided Radiofrequency Ablation for cT1a-b Renal Masses: Experience from Single High-Volume Referral Center , 2020, Cancers.
[8] S. Bhayani,et al. Ten-Year Experience with Percutaneous Cryoablation of Renal Tumors: Tumor Size Predicts Disease Progression. , 2020, Journal of endourology.
[9] P. Liang,et al. Percutaneous Microwave Ablation versus Laparoscopic Partial Nephrectomy for cT1a Renal Cell Carcinoma: A Propensity-matched Cohort Study of 1955 Patients. , 2020, Radiology.
[10] J. Cheville,et al. Oncologic Outcomes Following Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses. , 2019, European urology.
[11] S. Rais-Bahrami,et al. Percutaneous Cryoablation of Stage T1b Renal Cell Carcinoma: Safety, Technical Results, and Clinical Outcomes , 2019, CardioVascular and Interventional Radiology.
[12] S. Nakada,et al. Comparing Outcomes for Patients with Clinical T1b Renal Cell Carcinoma Treated with either Percutaneous Microwave Ablation or Surgery. , 2019, Urology.
[13] C. Porta,et al. Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†. , 2019, Annals of oncology : official journal of the European Society for Medical Oncology.
[14] R. Thompson,et al. Introduction of Microwave Ablation Into a Renal Ablation Practice: Valuable Lessons Learned. , 2018, AJR. American journal of roentgenology.
[15] M. Liss,et al. Partial Nephrectomy versus Thermal Ablation for Clinical Stage T1 Renal Masses: Systematic Review and Meta-Analysis of More than 3,900 Patients. , 2018, Journal of vascular and interventional radiology : JVIR.
[16] F. Orsi,et al. Tips and tricks for a safe and effective image-guided percutaneous renal tumour ablation , 2017, Insights into Imaging.
[17] S. Boorjian,et al. Percutaneous Cryoablation of Clinical T2 (> 7 cm) Renal Masses: Technical Considerations, Complications, and Short-Term Outcomes. , 2015, Journal of vascular and interventional radiology : JVIR.
[18] S. Boorjian,et al. Percutaneous cryoablation of stage T1b renal cell carcinoma: technique considerations, safety, and local tumor control. , 2015, Journal of vascular and interventional radiology : JVIR.
[19] J. Cheville,et al. Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses. , 2015, European urology.
[20] Lorenzo Marconi,et al. EAU guidelines on renal cell carcinoma: 2014 update. , 2010, European urology.
[21] T. Vogl,et al. Image-guided tumor ablation: standardization of terminology and reporting criteria--a 10-year update. , 2014, Journal of vascular and interventional radiology : JVIR.
[22] K. Katsanos,et al. Systematic Review and Meta-Analysis of Thermal Ablation Versus Surgical Nephrectomy for Small Renal Tumours , 2014, CardioVascular and Interventional Radiology.
[23] Jie Cai,et al. "Trifecta" in partial nephrectomy. , 2013, The Journal of urology.
[24] Samuel K. Park,et al. Radiofrequency ablation versus partial nephrectomy in patients with solitary clinical T1a renal cell carcinoma: comparable oncologic outcomes at a minimum of 5 years of follow-up. , 2012, European urology.
[25] Samuel K. Park,et al. Long-term outcomes of renal tumor radio frequency ablation stratified by tumor diameter: size matters. , 2012, The Journal of urology.
[26] B. Leibovich,et al. Percutaneous cryoablation of renal masses >or=3 cm: efficacy and safety in treatment of 108 patients. , 2010, Journal of endourology.
[27] Walter Artibani,et al. Preoperative aspects and dimensions used for an anatomical (PADUA) classification of renal tumours in patients who are candidates for nephron-sparing surgery. , 2009, European urology.
[28] M. Makuuchi,et al. The Clavien-Dindo Classification of Surgical Complications: Five-Year Experience , 2009, Annals of surgery.
[29] K. Takeda,et al. Radiofrequency Ablation Combined with Renal Arterial Embolization for the Treatment of Unresectable Renal Cell Carcinoma Larger Than 3.5 cm: Initial Experience , 2006, CardioVascular and Interventional Radiology.
[30] C. Mackenzie,et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.